Ethionamide

12
Ethionamide • A 2 nd line anti TB agent, analogue of isonicotinamide but it is di-substituted and contains S in place of O • It contains ethyl group at position 2

Transcript of Ethionamide

Page 1: Ethionamide

Ethionamide

• A 2nd line anti TB agent, analogue of isonicotinamide but it is di-substituted and contains S in place of O

• It contains ethyl group at position 2

Page 2: Ethionamide

• In vitro it is less active but in vivo more active because of increased lipocity due to C2H5

• Mechanism of action is similar to INH • Its active metabolite is ethionamide sulfoxide

Page 3: Ethionamide

Mechanism of action• Ethionamide upon oxidation with catalase-

peroxidase is converted to an active acylating agent, ethionamide sulfoxide, which inturn inactivate inhA enoyal reductase. It acylates cystine No. 243 in inhA protein

Page 4: Ethionamide

Mechanism of action

Ethionamide

Ethionamide sulfoxide

Page 5: Ethionamide

Metabolism• Less than 1% of the drug is excreted unchanged

in urine. Rest of the drug is excreted as one of the following metabolites, which are given as follows:

Page 6: Ethionamide

Cycloserine• Analogue of amino acid serine

and it exists in cyclic form- a five member ring containing O and N at an adjacent positions,

• Also called Isoxazolidine or oxazolidine• Obtained naturally as d-isomer• Contains Keto group at position 3 and NH2 at

position 4, which is in front• d-isomer is more active

Page 7: Ethionamide

• It is 2nd line anti TB drug first isolated from Streptomyces orchidaceus, but now being synthesized in laboratory

• It causes CNS toxicity• Bacteria become resistant after sometime • It acts on cell wall of bacteria and is not

selective against MT because all bacteria contain peptidoglycan

Page 8: Ethionamide

• It acts on normal peptidoglycan portion of cell wall rather than acting on outer layer of mycolic acid

• It inhibits alanine resemase and alanine ligase• Alanine resemase converts L-isomer of alanine

to d-isomer. Because only d-form can be incorporated into cell wall. Alanine is present in levo form, hence need to be converted to d-form

• Lygase is necessary for attachment of two alanine units

Page 9: Ethionamide
Page 10: Ethionamide

Synthesis

Page 11: Ethionamide

• Readily absorbed after oral administration and is widely distributed including CNS

• It binds to neuronal N-methyl, D-aspaartate receptor and effects the synthesis and metabolism of aminobutyric acid leading to serious CNS effects

Page 12: Ethionamide